Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) dropped 0.4% on Thursday . The company traded as low as €26.18 ($28.46) and last traded at €26.43 ($28.73). Approximately 3,972,932 shares changed hands during trading, The stock had previously closed at €26.53 ($28.84).
Bayer Aktiengesellschaft Price Performance
The stock has a 50 day simple moving average of €27.96 and a two-hundred day simple moving average of €27.52. The firm has a market cap of $25.97 billion, a PE ratio of -20.49, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The company has a debt-to-equity ratio of 129.94, a quick ratio of 0.72 and a current ratio of 1.27.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Read More
- Five stocks we like better than Bayer Aktiengesellschaft
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Top Biotech Stocks: Exploring Innovation Opportunities
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
